Q9983 – Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

Long description

Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries

Short description

Florbetaben f18 diagnostic

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

D Special coverage instructions apply

BETOS category

I1E Standard imaging - nuclear medicine

ASC

Approved for ambulatory surgical centers

Added

July 1, 2016

Last change

January 1, 2025 – No change

Nearby Q codes

• Q9975 – Injection, factor viii fc fusion protein (recombinant), per iu
• Q9976 – Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron
• Q9977 – Compounded drug, not otherwise classified
• Q9978 – Netupitant 300 mg and palonosetron 0.5 mg
• Q9979 – Injection, alemtuzumab, 1 mg
• Q9980 – Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg
• Q9981 – Rolapitant, oral, 1 mg
• Q9982 – Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries
• Q9984 – Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg
• Q9985 – Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg
• Q9986 – Injection, hydroxyprogesterone caproate, (makena), 10 mg
• Q9987 – Pathogen(s) test for platelets
• Q9988 – Platelets, pheresis, pathogen-reduced, each unit
• Q9989 – Ustekinumab, for intravenous injection, 1 mg
• Q9991 – Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg
• Q9992 – Injection, buprenorphine extended-release (sublocade), greater than 100 mg